-
1
-
-
0036241535
-
Involvement of cyclooxygenase-2 in osteoclast formation and bone destruction in bone metastasis of mammary carcinoma cell lines
-
Ono K., Akatsu T., Murakami T., Kitamura R., Yamamoto M., Rokutanda M., Nagata N., and Kugai N. Involvement of cyclooxygenase-2 in osteoclast formation and bone destruction in bone metastasis of mammary carcinoma cell lines. J. Bone Miner. Res. 17 (2002) 774-781
-
(2002)
J. Bone Miner. Res.
, vol.17
, pp. 774-781
-
-
Ono, K.1
Akatsu, T.2
Murakami, T.3
Kitamura, R.4
Yamamoto, M.5
Rokutanda, M.6
Nagata, N.7
Kugai, N.8
-
2
-
-
0035076411
-
Evidence for a direct role of cyclooxygenase-2 in implant wear debris induced osteolysis
-
Zhang X., Morham S.G., Langenbach R., Young D.A., Xing L., Boyce B.F., Puzas E.J., Rosier R.N., O'Keefe R.J., and Schwarz E.M. Evidence for a direct role of cyclooxygenase-2 in implant wear debris induced osteolysis. J. Bone Miner. Res. 16 (2001) 660-669
-
(2001)
J. Bone Miner. Res.
, vol.16
, pp. 660-669
-
-
Zhang, X.1
Morham, S.G.2
Langenbach, R.3
Young, D.A.4
Xing, L.5
Boyce, B.F.6
Puzas, E.J.7
Rosier, R.N.8
O'Keefe, R.J.9
Schwarz, E.M.10
-
3
-
-
0031000236
-
2 in young rats increase the osteogenic capacity of bone marrow
-
2 in young rats increase the osteogenic capacity of bone marrow. Bone 20 (1997) 521-526
-
(1997)
Bone
, vol.20
, pp. 521-526
-
-
Weinreb, M.1
Suponitzky, I.2
Keila, S.3
-
4
-
-
0036259278
-
Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair
-
Zhang X., Schwarz E.M., Young D.A., Puzas J., Rosier R.N., and O'Keefe R.J. Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. J. Clin. Invest. 109 (2002) 1405-1415
-
(2002)
J. Clin. Invest.
, vol.109
, pp. 1405-1415
-
-
Zhang, X.1
Schwarz, E.M.2
Young, D.A.3
Puzas, J.4
Rosier, R.N.5
O'Keefe, R.J.6
-
5
-
-
0034066978
-
Prostaglandin G/H synthase-2 is required for maximal formation of osteoclast-like cells in culture
-
Okada Y., Lorenzo J.A., Freeman A.M., Tomita M., Morham S.G., Raisz L.G., and Pilbeam C.C. Prostaglandin G/H synthase-2 is required for maximal formation of osteoclast-like cells in culture. J. Clin. Invest. 105 (2000) 823-832
-
(2000)
J. Clin. Invest.
, vol.105
, pp. 823-832
-
-
Okada, Y.1
Lorenzo, J.A.2
Freeman, A.M.3
Tomita, M.4
Morham, S.G.5
Raisz, L.G.6
Pilbeam, C.C.7
-
6
-
-
15444362701
-
2 signaling systems results in enhancement of osteoclastogenesis through effects on the OPG/RANKL/RANK system
-
2 signaling systems results in enhancement of osteoclastogenesis through effects on the OPG/RANKL/RANK system. Endocrinology 146 (2005) 1991-1998
-
(2005)
Endocrinology
, vol.146
, pp. 1991-1998
-
-
Liu, X.H.1
Kirschenbaum, A.2
Yao, S.3
Levine, A.C.4
-
7
-
-
33746387887
-
The effect of cyclooxygenase-2 inhibitors on bone mineral density results from the Canadian multicentre osteoporosis study
-
Richards J.B., Joseph L., Schwartzman K., Kreiger N., Tenenhouse A., and Goltzman D. The effect of cyclooxygenase-2 inhibitors on bone mineral density results from the Canadian multicentre osteoporosis study. Osteoporos. Int. 17 (2006) 1410-1419
-
(2006)
Osteoporos. Int.
, vol.17
, pp. 1410-1419
-
-
Richards, J.B.1
Joseph, L.2
Schwartzman, K.3
Kreiger, N.4
Tenenhouse, A.5
Goltzman, D.6
-
8
-
-
0036009724
-
2 on gene expression in primary osteoblastic cell from prostaglandin receptor knockout mice
-
2 on gene expression in primary osteoblastic cell from prostaglandin receptor knockout mice. Bone 30 (2002) 567-573
-
(2002)
Bone
, vol.30
, pp. 567-573
-
-
Li, X.1
Pilbeam, C.C.2
Pan, L.3
Breyer, R.M.4
Raisz, L.G.5
-
9
-
-
5044228112
-
Wnt signaling in osteoblasts and bone diseases
-
Westendorf J., Kahler R.A., and Schroeder T.M. Wnt signaling in osteoblasts and bone diseases. Gene 341 (2004) 19-39
-
(2004)
Gene
, vol.341
, pp. 19-39
-
-
Westendorf, J.1
Kahler, R.A.2
Schroeder, T.M.3
-
11
-
-
24744439747
-
Prostate cancer cells promote osteoblastic bone metastases through Wnts
-
Hall C.L., Bafico A., Dai J., Aaronson S.A., and Keller E.T. Prostate cancer cells promote osteoblastic bone metastases through Wnts. Cancer Res. 65 (2005) 7554-7560
-
(2005)
Cancer Res.
, vol.65
, pp. 7554-7560
-
-
Hall, C.L.1
Bafico, A.2
Dai, J.3
Aaronson, S.A.4
Keller, E.T.5
-
12
-
-
22044436959
-
How Wnt signaling affects bone repair by mesenchymal stem cells from the bone marrow
-
Gregory C.A., Gunn W.G., Reyes E., Smolarz A.J., Munoz J., Spees J.L., and Prockop D.J. How Wnt signaling affects bone repair by mesenchymal stem cells from the bone marrow. Ann. N. Y. Acad. Sci. 1049 (2005) 97-106
-
(2005)
Ann. N. Y. Acad. Sci.
, vol.1049
, pp. 97-106
-
-
Gregory, C.A.1
Gunn, W.G.2
Reyes, E.3
Smolarz, A.J.4
Munoz, J.5
Spees, J.L.6
Prockop, D.J.7
-
13
-
-
0032823306
-
Prostanoid receptors: structures, properties, and functions
-
Narumiya S., Sugimoto Y., and Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol. Rev. 79 (1999) 1193-1226
-
(1999)
Physiol. Rev.
, vol.79
, pp. 1193-1226
-
-
Narumiya, S.1
Sugimoto, Y.2
Ushikubi, F.3
-
14
-
-
0034455647
-
The role of prostaglandina E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: an análisis using specific agonists for the respective EPs
-
Suzawa T., Miyaura C., Inada M., Maruyama T., Sugimoto Y., Ushikubi F., Ichikawa A., Narumiya S., and Suda T. The role of prostaglandina E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: an análisis using specific agonists for the respective EPs. Endocrinology 141 (2000) 1554-1559
-
(2000)
Endocrinology
, vol.141
, pp. 1554-1559
-
-
Suzawa, T.1
Miyaura, C.2
Inada, M.3
Maruyama, T.4
Sugimoto, Y.5
Ushikubi, F.6
Ichikawa, A.7
Narumiya, S.8
Suda, T.9
-
15
-
-
34250877906
-
Androgen-induced Wnt signaling in pre-osteoblasts promotes the growth of MDA-PCa-2b human prostate cancer cells
-
Liu X.H., Kirschenbaum A., Yao S., Aaronson S.A., Liu G., and Levine A.C. Androgen-induced Wnt signaling in pre-osteoblasts promotes the growth of MDA-PCa-2b human prostate cancer cells. Cancer Res. 67 (2007) 5747-5753
-
(2007)
Cancer Res.
, vol.67
, pp. 5747-5753
-
-
Liu, X.H.1
Kirschenbaum, A.2
Yao, S.3
Aaronson, S.A.4
Liu, G.5
Levine, A.C.6
-
16
-
-
0037146555
-
2 induces hypoxia inducible factor-1α protein stabilization and nuclear localization in a human prostate cancer cell line
-
2 induces hypoxia inducible factor-1α protein stabilization and nuclear localization in a human prostate cancer cell line. J. Biol. Chem 277 (2002) 50081-50086
-
(2002)
J. Biol. Chem
, vol.277
, pp. 50081-50086
-
-
Liu, X.H.1
Kirchenbaum, A.2
Lu, M.3
Yao, S.4
Holland, J.F.5
Levine, A.C.6
-
17
-
-
25844509347
-
Canonical Wnt signaling promotes osteogenesis by directly stimulating Runx2 gene expression
-
Gaur T., Lengner C.J., Hovhannisyan H., Bhat R.A., Bodine P.V., Komm B.S., Javed A., van Wijnen A.J., Stein J.L., Stein G.S., and Lian J.B. Canonical Wnt signaling promotes osteogenesis by directly stimulating Runx2 gene expression. J. Biol. Chem. 280 (2005) 33132-33140
-
(2005)
J. Biol. Chem.
, vol.280
, pp. 33132-33140
-
-
Gaur, T.1
Lengner, C.J.2
Hovhannisyan, H.3
Bhat, R.A.4
Bodine, P.V.5
Komm, B.S.6
Javed, A.7
van Wijnen, A.J.8
Stein, J.L.9
Stein, G.S.10
Lian, J.B.11
-
18
-
-
60849091616
-
Bone morphogenetic protein-2 enhances Wnt/beta-catenin signaling-induced osteo-protegerin expression
-
Sata M.M., Nakashima A., Yawaka Y., and Tamura M. Bone morphogenetic protein-2 enhances Wnt/beta-catenin signaling-induced osteo-protegerin expression. Genes Cells 14 (2009) 141-153
-
(2009)
Genes Cells
, vol.14
, pp. 141-153
-
-
Sata, M.M.1
Nakashima, A.2
Yawaka, Y.3
Tamura, M.4
-
19
-
-
27844541752
-
Crosstalk between Wnt and bone morphogenetic protein-2 (BMP2) signaling in differentiation pathway of C2C12 myoblasts
-
Nakashima A., Katagirt T., and Tamura M. Crosstalk between Wnt and bone morphogenetic protein-2 (BMP2) signaling in differentiation pathway of C2C12 myoblasts. J. Biol. Chem. 280 (2005) 37660-3766820
-
(2005)
J. Biol. Chem.
, vol.280
, pp. 37660-3766820
-
-
Nakashima, A.1
Katagirt, T.2
Tamura, M.3
-
20
-
-
0034931501
-
Genetic pharmacological analysis of prostanoid receptor function
-
Narumiya S., and FitzGerald G.A. Genetic pharmacological analysis of prostanoid receptor function. J. Clin. Invest. 108 (2001) 25-3021
-
(2001)
J. Clin. Invest.
, vol.108
, pp. 25-3021
-
-
Narumiya, S.1
FitzGerald, G.A.2
-
21
-
-
22544475938
-
2 stimulates β-catenin/T cell factor-dependent transcription in colon cancer
-
2 stimulates β-catenin/T cell factor-dependent transcription in colon cancer. J. Biol. Chem. 280 (2005) 26565-26572
-
(2005)
J. Biol. Chem.
, vol.280
, pp. 26565-26572
-
-
Shao, J.1
Jung, C.2
Liu, C.3
Sheng, H.4
-
23
-
-
0034461612
-
Cyclic AMP promotes neuronal survival by phosphorylation of glycogen synthase kinase 3β
-
Li M., Wang X., Meintzer M.K., Laessig T., Birnbaum M.J., and Heidenreich K.A. Cyclic AMP promotes neuronal survival by phosphorylation of glycogen synthase kinase 3β. Mol. Cell. Biol. 20 (2000) 9356-9363
-
(2000)
Mol. Cell. Biol.
, vol.20
, pp. 9356-9363
-
-
Li, M.1
Wang, X.2
Meintzer, M.K.3
Laessig, T.4
Birnbaum, M.J.5
Heidenreich, K.A.6
-
24
-
-
12944250922
-
Phosphorylation and inactivation of glycogen synthase kinase 3β by protein kinase A
-
Fang X., Yu S.X., Lu Y., Bast R.C., Woodgett Jr. J.R., and Mills G.B. Phosphorylation and inactivation of glycogen synthase kinase 3β by protein kinase A. Proc. Natl. Acad. Sci. USA 97 (2000) 11960-11965
-
(2000)
Proc. Natl. Acad. Sci. USA
, vol.97
, pp. 11960-11965
-
-
Fang, X.1
Yu, S.X.2
Lu, Y.3
Bast, R.C.4
Woodgett Jr., J.R.5
Mills, G.B.6
-
26
-
-
0034284550
-
Therapeutic approaches to bone diseases
-
Rodan G.A., and Martin T.J. Therapeutic approaches to bone diseases. Science 289 (2000) 1508-1514
-
(2000)
Science
, vol.289
, pp. 1508-1514
-
-
Rodan, G.A.1
Martin, T.J.2
-
27
-
-
0030730232
-
The effects of programmed administration of human parathyroid hormone fragment (1-34) on bone histomorphometry and serum chemistry in rats
-
Dobnig H., and Turner R.T. The effects of programmed administration of human parathyroid hormone fragment (1-34) on bone histomorphometry and serum chemistry in rats. Endocrinology 138 (1997) 4607-4612
-
(1997)
Endocrinology
, vol.138
, pp. 4607-4612
-
-
Dobnig, H.1
Turner, R.T.2
|